Ribomic Inc
TSE:4591
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Ribomic Inc
Ribomic Inc
Total Receivables
Ribomic Inc
Total Receivables Peer Comparison
2160
4587
4974
2929
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ribomic Inc
TSE:4591
|
Total Receivables
¥64.3m
|
CAGR 3-Years
21%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Total Receivables
¥4.5B
|
CAGR 3-Years
45%
|
CAGR 5-Years
27%
|
CAGR 10-Years
60%
|
|
|
PeptiDream Inc
TSE:4587
|
Total Receivables
¥4.7B
|
CAGR 3-Years
87%
|
CAGR 5-Years
195%
|
CAGR 10-Years
35%
|
|
|
Takara Bio Inc
TSE:4974
|
Total Receivables
¥11.3B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Pharma Foods International Co Ltd
TSE:2929
|
Total Receivables
¥4.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
34%
|
CAGR 10-Years
25%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Total Receivables
¥608.7m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
8%
|
See Also
What is Ribomic Inc's Total Receivables?
Total Receivables
64.3m
JPY
Based on the financial report for Mar 31, 2024, Ribomic Inc's Total Receivables amounts to 64.3m JPY.
What is Ribomic Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
24%
Over the last year, the Total Receivables growth was -9%. The average annual Total Receivables growth rates for Ribomic Inc have been 21% over the past three years , 24% over the past five years .
You don't have any saved screeners yet
